The Sick Times

The Sick Times A non-profit news site covering the Long Covid crisis. Founded by Betsy Ladyzhets and Miles Griffis.

Here’s what’s happening this week in Long COVID research: 🫀Study: People with Long COVID are at a higher risk for cardio...
09/03/2026

Here’s what’s happening this week in Long COVID research:

🫀Study: People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary outcomes

🪖 NASEM announced a new study on the impact of SARS-CoV-2 infection across all age groups and its implications for the military

🫁 A new trial for myalgic encephalomyelitis will study Intermittent Hypoxia-Hyperoxia Treatment

💊 RECOVER-VITAL’s clinical trial testing Paxlovid for Long COVID has formally published their results

09/03/2026

On Friday, The Sick Times broke the news that the U.S. Department of Defense (DOD) is funding a new clinical trials program for Long COVID with an initial grant of $8 million.

Betsy Ladyzhets has more on her reporting for the story.

Comment NEWS and we’ll DM you a link to sign up for our newsletter, so you can stay on top of all the latest Long COVID reporting from The Sick Times.

On Friday, The Sick Times broke the news that the U.S. Department of Defense (DOD) is funding a new clinical trials prog...
09/02/2026

On Friday, The Sick Times broke the news that the U.S. Department of Defense (DOD) is funding a new clinical trials program for Long COVID with an initial grant of $8 million.

This week we have more reporting from Betsy Ladyzhets about PROBE-PASC, including:

* Context on past DOD medical research funding

* Comments and slides from Michael Peluso’s presentation at the International Society for Long COVID and Post-Acute Infection Syndromes (ISLC-PAIS) Conference in Amsterdam

* Comments from Long COVID advocates

* And a closer look at first clinical trial in the series, which will test the monoclonal antibody Pemgarda, along with the immune-modulating drug hydroxychloroquine

Comment NEWS and we’ll DM you a link to sign up for our newsletter, so you can stay on top of all the latest Long COVID reporting from The Sick Times.

Despite prior experience working in public health, Kelly Sealey has faced challenges getting care for Long COVID and chr...
09/01/2026

Despite prior experience working in public health,
Kelly Sealey has faced challenges getting care for Long COVID and chronic seizures.

This essay is part of the Color of Long COVID series, supported by the Disability Visibility Project.

BREAKING: The U.S. Department of Defense is funding a new clinical trials program for Long COVID with an initial grant o...
08/28/2026

BREAKING: The U.S. Department of Defense is funding a new clinical trials program for Long COVID with an initial grant of $8 million. Called PROBE-PASC, the program will focus on mechanistic trials that will study the disease’s underlying biology in tandem with testing promising treatments.

Michael Peluso, one of the lead investigators of the first trial in the new program, announced it at this week’s International Society for Long COVID Conference in Amsterdam. The first trial will test the monoclonal antibody Pemgarda along with the immune-modulating drug hydroxychloroquine, including arms with both drugs by themselves and the two in combination. Further studies in the PROBE-PASC program will follow similar approaches in testing potential hypotheses about what causes Long COVID at the same time as they test potential treatments.

Funding for PROBE-PASC comes through the Congressionally Directed Medical Research Programs (CDMRP), programs in which the Department of Defense (also called the Department of War following a Trump executive order last year) supports biomedical research for specific diseases and topics that Congress has designated as priorities.

✍ We'll be reporting more on this development soon.

📰 Comment "news" to get the latest Long COVID news delivered directly to your inbox by subscribing to our newsletter.

ID: 1. A graphic features an aerial photo of the U.S. Pentagon building. Text overlaid on the photo reads, “The Sick Times: Breaking: Department of Defense announces $8 million grant for Long COVID clinical trials”.

08/28/2026

Why is the CDC minimizing COVID-19 levels in wastewater during the summer surge? Betsy Ladyzhets is here to unpack it for you.

If you want a source that will never downplay ongoing COVID-19 spread, subscribe to The Sick Times newsletter. It included COVID-19 trends updates that Betsy writes every week, along with research news, upcoming events, advocacy alerts, opinion pieces from people with Long COVID and more.

You can comment NEWS, and we’ll DM you a link to subscribe. And please consider sharing our newsletter with your friends during our referral campaign.

👀 Another observational study found more evidence of endothelial dysfunction in Long COVID💊 A small clinical trial found...
08/27/2026

👀 Another observational study found more evidence of endothelial dysfunction in Long COVID

💊 A small clinical trial found a probiotic formula called VSL #3 helped improve fatigue in people with Long COVID

🧬 Small pieces of genetic molecules in the blood called “microRNA” may serve as a future biomarker for Long COVID

The end of summer may be approaching in the U.S., but our summer COVID-19 wave is showing no signs of slowing. All data ...
08/26/2026

The end of summer may be approaching in the U.S., but our summer COVID-19 wave is showing no signs of slowing. All data sources report significant increases in disease levels and outbreaks across the country.

08/25/2026

To help us grow our newsletter, we’re trying out a referral program. We think this will make it easier for readers like you to share the newsletter with other community members. But we need your help to test it out!

Here’s how it works:

✅ If you’re signed up for our newsletter already, you’ll get a referral link in today’s newsletter (8/25)!

✅ If you’re not already signed up for our newsletter, comment NEWS and we’ll send you a link to sign up!

You can share your referral link with friends, family members, neighbors, your medical providers, and so on. You can send it to them directly in an email or text, post it on social media, or share it in any other way you prefer.

If you’re successful in helping friends and community members sign up for our newsletter, we will say thank you by sending you rewards. Here’s what we have planned so far:

💌 With 1 successful referral, you’ll receive a thank-you note from our team.

🕊️ With 5 referrals, we will mail you a pack of Sick Times stickers*, designed by artists in the Long COVID community.

🧢 With 10 referrals, we will mail you a Sick Times hat!*

🌈 With 20 referrals, you’ll be invited to a one-on-one Q&A call with one of our editors, Miles and Betsy.

*While supplies last.

With this referral campaign, we are aiming to gain 1,000 new newsletter subscribers over the next ten days. If it’s successful, we will keep the referral program going over the coming months.

Help champion our journalism by sharing The Sick Times!

🦠 Preprint: Researchers found immune abnormalities in the intestines of people with Long COVID👩🏽‍⚕️ Report: One in four ...
08/20/2026

🦠 Preprint: Researchers found immune abnormalities in the intestines of people with Long COVID

👩🏽‍⚕️ Report: One in four healthcare workers infected with SARS-CoV-2 early in the pandemic in the U.K. have had Long COVID

💵 Preprint: Universal healthcare in the U.S. could save the lives of over 114,000 Americans a year

Address

New York, NY

Website

Alerts

Be the first to know and let us send you an email when The Sick Times posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Sick Times:

Shortcuts

Share

Category